Viewing Study NCT05807893

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2026-01-03 @ 7:12 PM
Study NCT ID: NCT05807893
Status: COMPLETED
Last Update Posted: 2024-11-13
First Post: 2023-03-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate the Safety and Efficacy of Serplulimab Plus Bevacizumab and Chemotherapy in NSCLC Patients With Brain Metastases
Sponsor: Sun Yat-sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer Stage II View
None Bevacizumab View
None Immunotherapy View
None Brain Metastases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None bevacizumab View
None Serplulimab View
None efficacy View
None non-small cell lung cancer View
None brain metastases View